| Literature DB >> 30731172 |
Dimitrios Rigopoulos1, Robert Baran2, Soumiya Chiheb3, Carlton Ralph Daniel4, Nilton Di Chiacchio5, Stamatis Gregoriou1, Chander Grover6, Eckart Haneke7, Matilde Iorizzo8, Marcel Pasch9, Bianca Maria Piraccini10, Phoebe Rich11, Bertrand Richert12, Natalia Rompoti13, Adam I Rubin14, Archana Singal6, Michela Starace10, Antonella Tosti15, Ioanna Triantafyllopoulou16, Martin Zaiac17.
Abstract
Nail involvement in psoriasis is common, and the severity of it does not always parallel the intensity of cutaneous disease. We created a consensus group, of which the aim was to provide practical recommendations for the treatment of nail psoriasis in patients without skin psoriasis or with mild skin lesions with no indication for a systemic treatment. This collaborative process was conducted by an international panel of dermatologists with special expertise in nail disorders, using formal consensus methods. During this process, the panel strived to establish an agreement regarding the definition of nail psoriasis, the severity of nail psoriasis, and treatment response. Treatment recommendations are provided regarding nail psoriasis severity and matrix or bed involvement. Few-nail disease was considered as nail psoriasis affecting ≤3 nails. In the case of matrix involvement only, intralesional steroid injections were considered the treatment of choice. Topical steroids alone or in combination with topical vitamin D analogues were suggested for nail psoriasis limited to the nail bed. For the systemic treatment of nail psoriasis acitretin, methotrexate, cyclosporine, small molecules, and biologics may be employed.Entities:
Keywords: consensus; guidelines; intralesional steroid injection; nail psoriasis; nail psoriasis recommendation; nail psoriasis treatment
Mesh:
Substances:
Year: 2019 PMID: 30731172 DOI: 10.1016/j.jaad.2019.01.072
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527